Citius Pharmaceuticals Inc

Research Citius Pharmaceuticals Inc (CTXR) on Bullrun: market cap USD 15.88M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCTXR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 15.88M
• Financial periodFY2025
• Net income-USD 39.74M

Valuation Snapshot

latest market cap is USD 15.88M.

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections;

Frequently asked questions

What is Citius Pharmaceuticals Inc's market cap?

Citius Pharmaceuticals Inc's market capitalization is USD 15.88M.

What does Citius Pharmaceuticals Inc do?

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma.